Lombard Odier & Cie (Bahamas)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$9.74M Buy
179,080
+22,080
+14% +$1.44M 3.7% 3
2015
Q2
$10.6M Buy
157,000
+13,500
+9% +$881K 3.7% 2
2015
Q1
$8.4M Buy
143,500
+39,800
+38% +$2.4M 3.04% 6
2014
Q4
$6.79M Buy
103,700
+101,500
+4,614% +$6.4M 2.5% 12
2014
Q3
$127K Hold
2,200
0.05% 63
2014
Q2
$124K Hold
2,200
0.05% 76
2014
Q1
$113K Sell
2,200
-17,000
-89% -$859K 0.04% 78
2013
Q4
$1.01M Buy
+19,200
New +$944K 0.4% 50

Other funds holding ABBV

Lombard Odier & Cie (Bahamas)'s ABBV Position: Q3 2015 in Review

Lombard Odier & Cie (Bahamas) increased its AbbVie (ABBV) stake by 14% in Q3 2015, buying an estimated $1.44M and bringing the position to 179,080 shares worth $9.74M. The position accounts for 3.7% of the portfolio, ranked #3.

Lombard Odier & Cie (Bahamas) first reported a position in ABBV in Q4 2013 and has held it in 8 quarters since. The position peaked at $10.6M in Q2 2015. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

  • Lombard Odier & Cie (Bahamas) held 179,080 shares of AbbVie worth $9.74M as of Q3 2015.
  • Lombard Odier & Cie (Bahamas) bought 22,080 AbbVie shares in Q3 2015, an estimated $1.44M.
  • AbbVie made up 3.7% of Lombard Odier & Cie (Bahamas)'s portfolio in Q3 2015, its #3 holding.
  • Lombard Odier & Cie (Bahamas) first reported a position in AbbVie in Q4 2013 and has held it in 8 quarters since.
  • Lombard Odier & Cie (Bahamas)'s AbbVie position peaked at $10.6M in Q2 2015.
  • 1,604 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Lombard Odier & Cie (Bahamas)'s 13F filing for Q3 2015, filed 13 Nov 2015.